DJIA 17,719.92 -78.57 -0.44%
NASDAQ 5,108.67 -18.86 -0.37%
S&P 500 2,080.41 -9.70 -0.46%
market minute promo

GlaxoSmithKline (NYSE: GSK)

40.51 -0.45 (-1.10%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $40.51 -1.10%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.88
Previous Close $40.96
Daily Range $40.49 - $40.96
52-Week Range $37.24 - $49.08
Market Cap $98.0B
P/E Ratio 14.08
Dividend (Yield) $2.33 (5.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,946,593
Average Daily Volume 3,781,363
Current FY EPS $2.39




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary Rss Feed

What Healthcare Dividend Stock Is Best?

One Motley Fool contributor evaluates three healthcare dividend companies to determine which may be the best investment.

The Most Important Message From Charlie Sheen's Recent HIV Admission

Charlie Sheen stunned the world with his HIV admission, but there's a far bigger lesson behind this announcement.

Buy-Rated Dividend Stocks In The Top 3: LHO, EPR, GSK

EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks

Healthcare's Greatest Dividend Stocks

Understanding the anatomy of great dividend-paying healthcare stocks, including what to look for and what to avoid.

3 High-Risk Dividend Stocks to Avoid

Despite the regular payouts they offer, some dividend stocks can be hazardous to your wealth.

Idera to Collaborate With GSK to Identify 3rd Generation Antisense Molecules for Treatment of Renal

Idera to Collaborate With GSK to Identify 3rd Generation Antisense Molecules for Treatment of Renal Disease

Buy European Stocks - Before The Going Gets Good

10 Healthcare Dogs Get 32.85% More Net Gains From 5 Lowest-Priced Stocks By Nov. 13, 2016

Salesforce Q3 Earnings Up Y/Y; Gains on Raised FY16 View

See More GSK News...

GSK's Top Competitors

GSK $40.51 (-1.10%)
Current stock: GSK
JNJ $101.24 (-1.10%)
Current stock: JNJ
PFE $32.77 (-0.06%)
Current stock: PFE
RHHBY $33.49 (0.00%)
Current stock: RHHBY